WELCOME TO CONTROL-T

Consortium for TCR-mediated Regulation and Oncogenesis in Lymphomas of T-cells

The Consortium for TCR-mediated Regulation and Oncogenesis in Lymphomas of T-cells (Control-T) is a DFG-funded association of five institutes located in Germany (Speaker: Prof. Martin-Leo Hansmann) with the aim to unravel mechanisms of T-cell lymphoma pathogenesis. Combining the individual expertise of each Control-T member, namely Pathology, Genetics, Hematology, Immunology and Bioinformatics, to focus on a single research area shall lead to novel insight into the pathobiology of this rare and so far less understood entity.

CONTROL-T MISSION

The mission of Control-T is to unravel the pathogenesis of T-cell lymphomas to facilitate development of novel therapeutic approaches in future.

ANNOUNCEMENT

The final CONTROL-T symposium is scheduled for Sept. 20-21, 2019, and it will take place in Essen. Details will be soon announced. Hope to see you there!